Kb. Chakrabarti et al., Modification of doxorubicin-induced cardiotoxicity: effect of essential fatty acids and ICRF-187 (dexrazoxane), EUR J CANC, 37(11), 2001, pp. 1435-1442
The capacity of an oil, containing gamma-linolenic acid (GLA), to reduce th
e severity of doxorubicin-induced cardiotoxicity has been investigated in a
rat model. Groups of 12-week-old, male, Sprague-Dawley rats were injected
intravenously (i.v.) with single doses (3 mg/kg body weight) of doxorubicin
(DOX). Daily for 1 week prior to DOX administration and for up to 20 weeks
afterwards groups of rats received either an oil containing both GLA and l
inoleic acid (So-1100, Scotia Pharmaceuticals), at two dose levels, or an o
il containing linoleic acid, but no GLA (So-1129) by oral gavage. Other gro
ups of rats received water as a control. One of the groups of rats that rec
eived water also received i.v. ICRF-187 (60 mg/kg) 15 min prior to DOX. A g
roup of animals acted as age-matched controls. The maximum reduction in bod
y weight in the first 2 weeks after the administration of DOX. was used as
a measure of acute toxicity. This was most severe in the group receiving a
combination of DOX and ICRF-LS7 (5.6 +/-0.43%). Animals receiving 2 mi of e
ither So-1100 or So-1129 were the least affected (approximate to2.5%). Meas
urements of cardiac volume output made at various intervals after DOX admin
istration indicated a approximate to 35% reduction in cardiac function in t
he control and So-1129 oil group after 20 weeks. The corresponding reductio
n in the groups receiving ICRF-187 and 2 mi of So-1100 was approximate to 1
6%. The group receiving daily doses of 1 mi So-1100 showed an intermediate
response. The death of an animal with signs of congestive cardiac failure o
ccurred in 40% of the animals in the DOX only control (water) group. There
were no deaths in the groups of rats receiving either ICRF-187 or pre- and
post-administration of 2 mi of So-1100. It was concluded that an oil contai
ning GLA (So-1100) has similar cardioprotective properties against DOX-indu
ced cardiotoxicity as ICRF-187, but with less general toxicity in this rat
model. (C) 2001 Published by Elsevier Science Ltd.